Concepedia

Yangzhi Ling

YL

10

Publications

325

Citations

10

H-Index

1991

Active since

Affiliations

University of Maryland, Baltimore(Current)

University of Manitoba

Peking University

Yangzhi Ling is an author at University of Maryland, Baltimore specializing in pharmacology, natural sciences, and molecular pharmacology.

Top concepts

Publications per year

1991–2006

10

Publications

10

17-Imidazolyl, Pyrazolyl, and Isoxazolyl Androstene Derivatives. Novel Steroidal Inhibitors of Human Cytochrome C<sub>l7,20</sub>-Lyase (P450<sub>17α</sub>)

Yangzhi Ling, Ji-song Li, Liu Yang et al. · Journal of Medicinal Chemistry · 1997 · 111 citations · Full text

Novel P45017α inhibitors: 17-(2′-oxazolyl)- and 17-(2′-thiazolyl)-androstene derivatives

Na Zhu, Yangzhi Ling, Xiaoping Lei et al. · Steroids · 2003 · 42 citations

, , +9

The effect of dexrazoxane (ICRF-187) on doxorubicin- and daunorubicin-mediated growth inhibition of Chinese hamster ovary cells

Brian B. Hasinoff, Jack C. Yalowich, Yangzhi Ling et al. · Anti-Cancer Drugs · 1996 · 35 citations

Synthesis and in vitro activity of some epimeric 20α-hydroxy, 20-oxime and aziridine pregnene derivatives as inhibitors of human 17α-hydroxylase/c17,20-lyase and 5α-reductase

Yangzhi Ling, Ji-song Li, Katsuya Kato et al. · Bioorganic & Medicinal Chemistry · 1998 · 33 citations

Synthesis of 20-hydroxy-, 20-amino-, and 20-nitro-14-hydroxy-21-nor-5.beta.,14.beta.-pregnane C-3 glycosides and related derivatives: structure-activity relationships of pregnanes that bind to the digitalis receptor

John F. Templeton, Yangzhi Ling, Talal H. Zeglam et al. · Journal of Medicinal Chemistry · 1993 · 31 citations

Rows per page

1–5 of 10